These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cocoyam ( Eleazu K; Maduabuchi Aja P; Eleazu CO Drug Chem Toxicol; 2022 Sep; 45(5):1923-1933. PubMed ID: 33641553 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis. Karunasagara S; Hong GL; Jung DY; Kim KH; Cho K; Jung JY PLoS One; 2020; 15(8):e0236879. PubMed ID: 32790676 [TBL] [Abstract][Full Text] [Related]
6. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase. Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726 [TBL] [Abstract][Full Text] [Related]
7. Inhibitors of 5alpha-reductase in the treatment of benign prostatic hyperplasia. Tarter TH; Vaughan ED Curr Pharm Des; 2006; 12(7):775-83. PubMed ID: 16515494 [TBL] [Abstract][Full Text] [Related]
8. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. Bartsch G; Rittmaster RS; Klocker H World J Urol; 2002 Apr; 19(6):413-25. PubMed ID: 12022710 [TBL] [Abstract][Full Text] [Related]
9. Psoralea corylifolia L. extract ameliorates benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis. Kim HJ; Jin BR; An HJ J Ethnopharmacol; 2021 Jun; 273():113844. PubMed ID: 33485982 [TBL] [Abstract][Full Text] [Related]
10. Additive effect of oral LDD175 to tamsulosin and finasteride in a benign prostate hyperplasia rat model. Choi BR; Kim HK; Soni KK; Karna KK; Lee SW; So I; Park JK Drug Des Devel Ther; 2018; 12():1855-1863. PubMed ID: 29970959 [TBL] [Abstract][Full Text] [Related]
11. The extract of Celtis choseniana Nakai alleviates testosterone-induced benign prostatic hyperplasia through inhibiting 5α reductase type 2 and the Akt/NF-κB/AR pathway. Hong GL; Kim TW; Lee HJ; Kim YJ; Kim KH; Jung JY Chin J Nat Med; 2022 Jul; 20(7):518-526. PubMed ID: 35907650 [TBL] [Abstract][Full Text] [Related]
12. Administration of Sasidharan S; Kp S; Bhaumik A; Kanti Das S; Nair J H Res Rep Urol; 2022; 14():225-239. PubMed ID: 35651598 [TBL] [Abstract][Full Text] [Related]
13. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia. Traish AM; Haider KS; Doros G; Haider A Horm Mol Biol Clin Investig; 2015 Sep; 23(3):85-96. PubMed ID: 26053014 [TBL] [Abstract][Full Text] [Related]
14. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model. Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224 [TBL] [Abstract][Full Text] [Related]
15. Effect of Choi YJ; Kim EK; Fan M; Tang Y; Hwang YJ; Sung SH Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31591335 [No Abstract] [Full Text] [Related]
16. Therapeutic role of Glycyrrhiza Uralensis fisher on benign prostatic hyperplasia through 5 alpha reductase regulation and apoptosis. Park JY; Park WY; Park J; Ahn KS; Lee JH; Kwak HJ; Um JY Phytomedicine; 2022 Oct; 105():154371. PubMed ID: 35964456 [TBL] [Abstract][Full Text] [Related]
17. Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats. Hwangbo H; Kwon DH; Choi EO; Kim MY; Ahn KI; Ji SY; Kim JS; Kim KI; Park NJ; Kim BH; Kim GY; Hong SH; Park C; Jeong JS; Choi YH Nutr Res Pract; 2018 Oct; 12(5):378-386. PubMed ID: 30323905 [TBL] [Abstract][Full Text] [Related]
18. A randomized placebo-controlled study: Phellodendron Bawei tablets combined with standard management can improve storage symptoms, sleep quality, and medication compliance in patients with benign prostatic hyperplasia compared to placebo with standard management. Gong YC; Chen X; Song QT; Gan Y; Zhang B; Li BS; Chen Z; He Y Transl Androl Urol; 2021 Aug; 10(8):3423-3431. PubMed ID: 34532267 [TBL] [Abstract][Full Text] [Related]
19. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function. Lowe FC BJU Int; 2005 Jun; 95 Suppl 4():12-8. PubMed ID: 15871731 [TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of 5-α reductase and in vivo suppression of benign prostatic hyperplasia by Physalis angulata ethyl acetate extract. Nguyen NP; Le QG; Truong VN; Nguyen TND; Phan NTT; Tran MH Fitoterapia; 2024 Jun; 175():105950. PubMed ID: 38599338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]